Recent studies add evidence to a prior phase 3 clinical trial, suggesting that taking the diabetes drug during acute COVID-19 reduces the risk of long-term symptoms. The post Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used? first appeared on The Sick Times.
